نتایج جستجو برای: neurooncology

تعداد نتایج: 163  

2007
W. Grisold R. Galvin V. Lisnic J. Lopes Lima E. Mueller D. B. Vodusek

W. Grisold, R. Galvin, V. Lisnic, J. Lopes Lima, E. Mueller, St. Oberndorfer, D. B. Vodusek and UEMS-EBN and EFNS Education Committee Departments of Neurology and Ludwig Boltzmann Institute for Neurooncology , Kaiser Franz Josef Hospital of the City of Vienna, Vienna, Austria; Department of Neurology, Cork University Hospital, Cork, Ireland; Department of Neurology, Medical University, Chisinau...

Journal: :Cancer research 2014
Nathan S White Carrie McDonald Niky Farid Josh Kuperman David Karow Natalie M Schenker-Ahmed Hauke Bartsch Rebecca Rakow-Penner Dominic Holland Ahmed Shabaik Atle Bjørnerud Tuva Hope Jona Hattangadi-Gluth Michael Liss J Kellogg Parsons Clark C Chen Steve Raman Daniel Margolis Robert E Reiter Leonard Marks Santosh Kesari Arno J Mundt Christopher J Kane Bob S Carter William G Bradley Anders M Dale

Diffusion-weighted imaging (DWI) has been at the forefront of cancer imaging since the early 2000s. Before its application in clinical oncology, this powerful technique had already achieved widespread recognition due to its utility in the diagnosis of cerebral infarction. Following this initial success, the ability of DWI to detect inherent tissue contrast began to be exploited in the field of ...

Journal: :Journal of biomedical optics 2015
Anatoly B Uzdensky Elena Berezhnaya Vera Kovaleva Marya Neginskaya Mikhail Rudkovskii Svetlana Sharifulina

Photodynamic therapy (PDT) effect is a promising adjuvant modality for diagnosis and treatment of brain cancer. It is of importance that the bright fluorescence of most photosensitizers provides visualization of brain tumors. This is successfully used for fluorescence-guided tumor resection according to the principle “to see and to treat.”Non-oncologic application of PDT effect for induction of...

Journal: :Cancer control : journal of the Moffitt Cancer Center 2005
Nicholas Butowski Susan M Chang

BACKGROUND The prognosis for most patients with primary brain tumors remains poor. Recent advances in molecular and cell biology have led to a greater understanding of molecular alterations in brain tumors. These advances are being translated into new therapies that will hopefully improve the prognosis for patients with brain tumors. METHODS We reviewed the literature on small molecule target...

Journal: :Cancer research 2007
Jonathan Kimmelman Josephine Nalbantoglu

Although relatively rare, malignant glioma (MG) is frequently used for testing novel cancer treatments. However, human MG trials have often been initiated on the basis of preclinical models that involve numerous discontinuities with the human disease. Below, we discuss various limitations of the mainstay model used in MG preclinical research, the murine orthotopic xenograft. After discussing al...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید